← SynDRA
DANEGAPTIDE
SynDRA canonical compound SYN0019514 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | gap junction modulator |
Mechanisms of action (all sources)
Cross-references
Synonyms
- Danegaptida
- GAP-134
- ZP-1609
- ZP1609
- SCHEMBL2399760
- BCP17534
- ZP 1609
- PA0Y7735AT
- glycyl-(4R)-4-(benzoylamino)-L-proline
- L-Proline, glycyl-4-(benzoylamino)-, (4R)-
- danegaptidum
- RefChem:919625
- DTXCID301510295
- MFCD16619374
- Danegaptide [USAN]
- Danegaptide [USAN:INN]
- UNII-PA0Y7735AT
- DANEGAPTIDE [INN]
- Danegaptide (USAN/INN)
- DANEGAPTIDE [WHO-DD]
- SCHEMBL2399763
- (2S,4R)-4-benzamido-1-glycylpyrrolidine-2-carboxylic acid
- BIZKIHUJGMSVFD-MNOVXSKESA-N
- CHEBI:177853
- AKOS030527026
- CS-1100
- HY-10913
- DB-289821
- NS00072457
- D09599
- D95155
- BRD-K35589454-003-01-1
- orb1307064
- DA-73655
- CS-1101
- Glycyl-(4R)-4-benzamido-L-proline--hydrogen chloride (1/1)
- GAP-134 (Hydrochloride)
- danegaptide hcl
Look up DANEGAPTIDE in the interactive SynDRA portal →